Notably, tumors with the enhanced expression of HOX genes, high EGFR expression plus unmethylated MGMT were associated with short survival [72], suggesting the involvement of a tumor stem-cell phenotype in the escape of tumor cells from radio-chemotherapy. The gene discussed is EGFR; the disease is neoplasm.